ERBB2 and neoplasm: It is well-established that HER2-overexpressing or triple negative breast cancer developed more local recurrence disease and distant metastases than luminal subtypes.20,24 We and others6,13 also observed that high-risk patients with higher histologic grade or more advanced tumor or nodal disease received less immediate breast reconstruction treatment than low-risk women.